About Melt Pharmaceuticals

About company

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures. Its novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers. Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing. It is headquartered in Needham, Massachusetts.